Pharmaceutical

Talaris Therapeutics to merge with Tourmaline Bio

Talaris Therapeutics has entered into a definitive agreement to merge with late-stage clinical biotechnology company Tourmaline Bio.

Jun 23, 2023 - 20:00
Talaris Therapeutics to merge with Tourmaline Bio
Talaris Therapeutics has entered into a definitive agreement to merge with late-stage clinical biotechnology company Tourmaline Bio.
Read the original article

Tags:

Previous Article

Erasca’s ERAS-801 gains FDA orphan drug designation for glioblastoma

Next Article

Kymera’s novel MDM2 degrader granted orphan designation for AML

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA approves AbbVie-Genmab’s Epkinly to treat DLBCL

FDA approves AbbVie-Genmab’s Epkinly to treat DLBCL

May 22, 2023

STAT+: Syndax’s leukemia drug succeeds in pivotal study

STAT+: Syndax’s leukemia drug succeeds in pivotal study

Oct 2, 2023

STAT+: Republicans consider a new attack on Biden ‘march-in’ plan for lower drug prices

STAT+: Republicans consider a new attack on Biden ‘marc...

Mar 6, 2024